While the COVID-19 pandemic has temporarily disrupted the recruitment, retention, and progress of many clinical trials across the globe, providers, pharma companies and research organizations continue to press on however they can with the exploration of potentially lifesaving medications and clinical interventions. Whether or not your clinical-trial efforts have been impacted by the pandemic, the last thing you want is to experience more protracted delays and complications because your organization wasn’t adhering to proper best practices and protocols for success. To be most effective, clinical trials need to be fully representative of the targeted population, offer full assurance of confidentiality and privacy, be easy to engage with throughout the process and offer accessibility, safety and a sense of partnership to the patients who participate in them.
There are a great many factors to consider when initiating this process, from pre-trial recruitment practices to initial engagement and onboarding practices to consistency of communication and transparency and more. By better understanding what patients need and look for in a clinical-trial experience, and the best and most efficient ways to offer it, you can avoid issues with regulatory compliance, patient accessibility, high drop-out rates and other factors that so commonly inhibit progress of these studies.